Cargando…

Topical treatment with fresh human milk versus emollient on atopic eczema spots in young children: a small, randomized, split body, controlled, blinded pilot study

BACKGROUND: Public health nurses report on effects of fresh human milk as treatment for conjunctivitis, rhinitis and atopic eczema (AE), the latter being highly prevalent in early childhood. Emollients and topical corticosteroids are first line treatment of AE. As many caregivers have steroid phobia...

Descripción completa

Detalles Bibliográficos
Autores principales: Berents, Teresa Løvold, Rønnevig, Jørgen, Søyland, Elisabeth, Gaustad, Peter, Nylander, Gro, Løland, Beate Fossum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424556/
https://www.ncbi.nlm.nih.gov/pubmed/25935520
http://dx.doi.org/10.1186/s12895-015-0027-9
_version_ 1782370349390757888
author Berents, Teresa Løvold
Rønnevig, Jørgen
Søyland, Elisabeth
Gaustad, Peter
Nylander, Gro
Løland, Beate Fossum
author_facet Berents, Teresa Løvold
Rønnevig, Jørgen
Søyland, Elisabeth
Gaustad, Peter
Nylander, Gro
Løland, Beate Fossum
author_sort Berents, Teresa Løvold
collection PubMed
description BACKGROUND: Public health nurses report on effects of fresh human milk as treatment for conjunctivitis, rhinitis and atopic eczema (AE), the latter being highly prevalent in early childhood. Emollients and topical corticosteroids are first line treatment of AE. As many caregivers have steroid phobia, alternative treatment options for mild AE are of interest. The aim of this small pilot study was to assess the potential effects and risks of applying fresh human milk locally on eczema spots in children with AE. METHODS: This was a split body, controlled, randomized and physician blinded pilot study, of children with AE with two similar contralateral eczema spots having a mother breastfeeding the child or a sibling. Fresh expressed milk and emollient was applied on the intervention spot and emollient alone on the control area, three times a day for four weeks. The severity and area of the eczema spots was evaluated weekly, and samples from milk and the spots were analysed weekly with respect to bacterial colonisation. RESULTS: Of nine patients included, six completed the study. Mean age at inclusion was 18.5 months. The spots examined were localized on the arms, legs or cheeks. The spots were similar in severity, but differed in area. In one patient the eczema ceased after inclusion. In four patients both control and intervention areas increased during the intervention. The relative change in eczema area compared to baseline showed less increase in the intervention spots in two patients, whereas the opposite was observed in three. In four children Staphylococcus aureus was found in their eczema once or more. In three of the 28 human milk samples, Staphylococcus aureus, alfa haemolytic streptococci or coagulase negative staphylococci were detected. Staphylococcus aureus was found once both in human milk and in the eczema spots, no clinical signs of infection were however observed. No secondary infection due to milk application was detected. CONCLUSION: In this small pilot study, no effect was found on eczema spots treated with topical application of fresh human milk. (ClinicalTrials.gov Identifier, NCT02381028).
format Online
Article
Text
id pubmed-4424556
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44245562015-05-09 Topical treatment with fresh human milk versus emollient on atopic eczema spots in young children: a small, randomized, split body, controlled, blinded pilot study Berents, Teresa Løvold Rønnevig, Jørgen Søyland, Elisabeth Gaustad, Peter Nylander, Gro Løland, Beate Fossum BMC Dermatol Research Article BACKGROUND: Public health nurses report on effects of fresh human milk as treatment for conjunctivitis, rhinitis and atopic eczema (AE), the latter being highly prevalent in early childhood. Emollients and topical corticosteroids are first line treatment of AE. As many caregivers have steroid phobia, alternative treatment options for mild AE are of interest. The aim of this small pilot study was to assess the potential effects and risks of applying fresh human milk locally on eczema spots in children with AE. METHODS: This was a split body, controlled, randomized and physician blinded pilot study, of children with AE with two similar contralateral eczema spots having a mother breastfeeding the child or a sibling. Fresh expressed milk and emollient was applied on the intervention spot and emollient alone on the control area, three times a day for four weeks. The severity and area of the eczema spots was evaluated weekly, and samples from milk and the spots were analysed weekly with respect to bacterial colonisation. RESULTS: Of nine patients included, six completed the study. Mean age at inclusion was 18.5 months. The spots examined were localized on the arms, legs or cheeks. The spots were similar in severity, but differed in area. In one patient the eczema ceased after inclusion. In four patients both control and intervention areas increased during the intervention. The relative change in eczema area compared to baseline showed less increase in the intervention spots in two patients, whereas the opposite was observed in three. In four children Staphylococcus aureus was found in their eczema once or more. In three of the 28 human milk samples, Staphylococcus aureus, alfa haemolytic streptococci or coagulase negative staphylococci were detected. Staphylococcus aureus was found once both in human milk and in the eczema spots, no clinical signs of infection were however observed. No secondary infection due to milk application was detected. CONCLUSION: In this small pilot study, no effect was found on eczema spots treated with topical application of fresh human milk. (ClinicalTrials.gov Identifier, NCT02381028). BioMed Central 2015-05-04 /pmc/articles/PMC4424556/ /pubmed/25935520 http://dx.doi.org/10.1186/s12895-015-0027-9 Text en © Berents et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Berents, Teresa Løvold
Rønnevig, Jørgen
Søyland, Elisabeth
Gaustad, Peter
Nylander, Gro
Løland, Beate Fossum
Topical treatment with fresh human milk versus emollient on atopic eczema spots in young children: a small, randomized, split body, controlled, blinded pilot study
title Topical treatment with fresh human milk versus emollient on atopic eczema spots in young children: a small, randomized, split body, controlled, blinded pilot study
title_full Topical treatment with fresh human milk versus emollient on atopic eczema spots in young children: a small, randomized, split body, controlled, blinded pilot study
title_fullStr Topical treatment with fresh human milk versus emollient on atopic eczema spots in young children: a small, randomized, split body, controlled, blinded pilot study
title_full_unstemmed Topical treatment with fresh human milk versus emollient on atopic eczema spots in young children: a small, randomized, split body, controlled, blinded pilot study
title_short Topical treatment with fresh human milk versus emollient on atopic eczema spots in young children: a small, randomized, split body, controlled, blinded pilot study
title_sort topical treatment with fresh human milk versus emollient on atopic eczema spots in young children: a small, randomized, split body, controlled, blinded pilot study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424556/
https://www.ncbi.nlm.nih.gov/pubmed/25935520
http://dx.doi.org/10.1186/s12895-015-0027-9
work_keys_str_mv AT berentsteresaløvold topicaltreatmentwithfreshhumanmilkversusemollientonatopiceczemaspotsinyoungchildrenasmallrandomizedsplitbodycontrolledblindedpilotstudy
AT rønnevigjørgen topicaltreatmentwithfreshhumanmilkversusemollientonatopiceczemaspotsinyoungchildrenasmallrandomizedsplitbodycontrolledblindedpilotstudy
AT søylandelisabeth topicaltreatmentwithfreshhumanmilkversusemollientonatopiceczemaspotsinyoungchildrenasmallrandomizedsplitbodycontrolledblindedpilotstudy
AT gaustadpeter topicaltreatmentwithfreshhumanmilkversusemollientonatopiceczemaspotsinyoungchildrenasmallrandomizedsplitbodycontrolledblindedpilotstudy
AT nylandergro topicaltreatmentwithfreshhumanmilkversusemollientonatopiceczemaspotsinyoungchildrenasmallrandomizedsplitbodycontrolledblindedpilotstudy
AT lølandbeatefossum topicaltreatmentwithfreshhumanmilkversusemollientonatopiceczemaspotsinyoungchildrenasmallrandomizedsplitbodycontrolledblindedpilotstudy